Prostate Cancer - Protein in prostate cancer may prevent tumor from spreading to the bone
Can't see this email? View it online
   
  Prostate Cancer  
  The latest prostate cancer news from News Medical  
 Better late than never: clinical guidelines are too late to screen for prostate cancerBetter late than never: clinical guidelines are too late to screen for prostate cancer
 
Men with a family history of prostate cancer may need to be screened up to 11 years before guidelines require.
 
   Protein in prostate cancer may prevent tumor from spreading to the boneProtein in prostate cancer may prevent tumor from spreading to the bone
 
Prostate cancer is the second most common cancer among men, according to the American Cancer Society. It's also one of the trickiest cancers to diagnose and treat.
 
   Study: A subset of patients with localized prostate cancer may benefit from immunotherapiesStudy: A subset of patients with localized prostate cancer may benefit from immunotherapies
 
In recent years, cancer immunotherapy has been effective in treating patients with immunogenic, or so-called "hot" tumors with increased levels of inflammation and the presence of immune cells in and around the tumors.
 
   Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancerArtificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer
 
Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men.
 
   New treatment option offers disease control and extends life in patients with advanced prostate cancerNew treatment option offers disease control and extends life in patients with advanced prostate cancer
 
Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy.